<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-4c18-79df-014c-20a0e46900c0</uuid><title>Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy</title><shortTitle>Diab_Retin_Mac_Edema</shortTitle><emeasureid>167</emeasureid><guid>50164228-9d64-4efc-af67-da0547ff61f1</guid><version>4.0.000</version><nqfid extension="0088" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3d61-56a7-013e-57fe7eeb37dd"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="2.16.840.1.113883.3.526">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</steward><developers><developer id="2.16.840.1.113883.3.526">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy and the presence or absence of macular edema during one or more office visits within 12 months</description><copyright>Copyright 2014 American Medical Association. All Rights Reserved.</copyright><disclaimer>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement(R) (PCPI[R]). These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA (on behalf of the PCPI). Neither the AMA, PCPI, nor its members shall be responsible for any use of the Measures. &#xD;
&#xD;
The National Committee for Quality Assurance's significant past efforts and contributions to the development and updating of the Measures is acknowledged.  &#xD;
&#xD;
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. &#xD;
&#xD;
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, PCPI, and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications. &#xD;
&#xD;
CPT(R) contained in the Measure specifications is copyright 2004-2014 American Medical Association. LOINC(R) copyright 2004-2014 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2014 International Health Terminology Standards Development Organisation. ICD-10 copyright 2014 World Health Organization. All Rights Reserved.&#xD;
&#xD;
Due to technical limitations, registered trademarks are indicated by (R) or [R].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount/><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Diabetic retinopathy is a leading cause of new cases of legal blindness among working-age Americans and represents a leading cause of blindness in this age group worldwide. (Klein, 2007). In 2005-2008, the estimated prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was 28.5 percent among persons with diabetes aged 40 years and older (Zhang, 2010). Approximately 1.5% of adults with diabetes had proliferative diabetic retinopathy and 2.7% had clinically significant macular edema (Zhang, 2010). &#xD;
&#xD;
Several level 1 RCT studies demonstrate the ability of timely treatment to reduce the rate and severity of vision loss from diabetes (Diabetic Retinopathy Study -- DRS, Early Treatment Diabetic Retinopathy Study -- ETDRS). Necessary examination prerequisites to applying the study results are that the presence and severity of both peripheral diabetic retinopathy and macular edema be accurately documented. In the RAND chronic disease quality project, while administrative data indicated that roughly half of the patients had an eye exam in the recommended time period, chart review data indicated that only 19% had documented evidence of a dilated examination (McGlynn, 2003). Thus, ensuring timely treatment that could prevent 95% of the blindness due to diabetes requires the performance and documentation of key examination parameters. The documented level of severity of retinopathy and the documented presence or absence of macular edema assists with the on-going plan of care for the patient with diabetic retinopathy.</rationale><recommendations>Because treatment is effective in reducing the risk of visual loss, detailed examination is indicated to assess for the following features that often lead to visual impairment: presence of macular edema, optic nerve neovascularization and/or neovascularization elsewhere, signs of severe NPDR (extensive retinal hemorrhages/microaneurysms, venous beading, and IRMA), and vitreous or preretinal hemorrhage. (Good evidence; Strong recommendation) (AAO, 2014)</recommendations><improvementNotations>Higher score indicates better quality</improvementNotations><references><reference>American Academy of Ophthalmology Retina/Vitreous Panel. Preferred Practice Pattern Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2014.</reference><reference>Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179-83. </reference><reference>Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649-56. </reference><reference>McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635-45.</reference></references><definitions>Documentation - The medical record must include: documentation of the level of severity of retinopathy AND documentation of whether macular edema was present or absent &#xD;
&#xD;
Macular Edema - Acceptable synonyms for macular edema include: macular thickening, intraretinal thickening, serous detachment of the retina, or pigment epithelial detachment &#xD;
&#xD;
Severity of Retinopathy - Mild nonproliferative, moderate nonproliferative, severe nonproliferative, very severe nonproliferative, proliferative</definitions><guidance>The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but ICD-9-CM and SNOMED-CT do not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible professional will record laterality in the patient medical record, as quality care and clinical documentation should include laterality.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>All patients aged 18 years and older with a diagnosis of diabetic retinopathy</initialPopDescription><denominatorDescription>Equals Initial Population</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Patients who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy AND the presence or absence of macular edema during one or more office visits within 12 months</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>Documentation of medical reason(s) for not performing a dilated macular or fundus examination&#xD;
Documentation of patient reason(s) for not performing a dilated macular or fundus examination</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measurePopulationExclusionsDescription>Not Applicable</measurePopulationExclusionsDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="20f6647c-0a03-4d2b-b67b-1d00f5552d93">None</qualityMeasureSet>
<finalizedDate value="201503302151-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d61-56a7-013e-57fe7eea37d8" name="ONC Administrative Sex"/><elementRef id="40280381-3d61-56a7-013e-57fe7eea37d9" name="Race"/><elementRef id="40280381-3d61-56a7-013e-57fe7eea37da" name="Ethnicity"/><elementRef id="40280381-3d61-56a7-013e-57fe7eeb37db" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="Age greater than or equal to 18 at MP" qdmVariable="false" uuid="989D2EBB-D8D9-4F2E-823D-BD0E59CD7D78"><functionalOp displayName="Age &gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-57fe7eeb37dd" type="qdm"/></functionalOp></subTree><subTree displayName="EyeCareEncounters" qdmVariable="true" uuid="ADA4CB52-A591-4C54-88FC-4AF0C038B1FB"><relationalOp displayName="During" type="DURING"><setOp displayName="UNION" type="union"><elementRef displayName="Ophthalmological Services : Encounter, Performed" id="05ab18cc-304f-4661-a90a-3e8ab02c4081" type="qdm"/><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="2bcb769b-ead5-4ff0-b60b-fb9f092fc4ef" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="68ef4e4b-4749-4cc1-9d36-c6dbd7aaea58" type="qdm"/><elementRef displayName="Office Visit : Encounter, Performed" id="454f4c4b-4f9f-4ecc-8a7d-46f5cad09f41" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="fc8a184a-8b37-4029-a268-c878ef687efb" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="8f34391b-9bf2-49fb-bebc-72a137772377" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-57fe7eeb37dd" type="qdm"/></relationalOp></subTree><subTree displayName="Occurrence A of $EyeCareEncounters" instance="A" instanceOf="ADA4CB52-A591-4C54-88FC-4AF0C038B1FB" qdmVariable="true" uuid="A07FE269-0647-404E-8E32-F66D2CF4F58C"><relationalOp displayName="During" type="DURING"><setOp displayName="UNION" type="union"><elementRef displayName="Ophthalmological Services : Encounter, Performed" id="05ab18cc-304f-4661-a90a-3e8ab02c4081" type="qdm"/><elementRef displayName="Care Services in Long-Term Residential Facility : Encounter, Performed" id="2bcb769b-ead5-4ff0-b60b-fb9f092fc4ef" type="qdm"/><elementRef displayName="Nursing Facility Visit : Encounter, Performed" id="68ef4e4b-4749-4cc1-9d36-c6dbd7aaea58" type="qdm"/><elementRef displayName="Office Visit : Encounter, Performed" id="454f4c4b-4f9f-4ecc-8a7d-46f5cad09f41" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="fc8a184a-8b37-4029-a268-c878ef687efb" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="8f34391b-9bf2-49fb-bebc-72a137772377" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-57fe7eeb37dd" type="qdm"/></relationalOp></subTree><subTree displayName="Diagnostic Study Perf Macular Exam result Level of Sev during EyeCareEnc" qdmVariable="false" uuid="3AE635EB-AF32-4659-ADA5-647388DA247D"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Macular Exam : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" type="qdm"/><relationalOp displayName="During" type="DURING"><elementRef displayName="Macular Exam : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" type="qdm"><attribute attrUUID="74a7dcb3-c2ba-4f70-8b96-9336f45c7d24" mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-57fe7eeb37ed"/></elementRef><subTreeRef displayName="Occurrence A of EyeCareEncounters" id="A07FE269-0647-404E-8E32-F66D2CF4F58C" type="subTree"/></relationalOp><functionalOp displayName="SATISFIES ANY" type="SATISFIES ANY"><elementRef displayName="Macular Exam : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" type="qdm"/><elementRef displayName="Macular Exam : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" type="qdm"><attribute attrUUID="ea0efc8d-4fe1-4d66-875e-b0c744c4c007" mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-57fe7eeb37ee"/></elementRef><elementRef displayName="Macular Exam : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" type="qdm"><attribute attrUUID="017eb8cb-6013-4b21-acdf-0ec83d078216" mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-57fe7eeb37ef"/></elementRef></functionalOp></functionalOp></subTree><subTree displayName="Union of Diag Study Perf not done during EyeCareEncounters" qdmVariable="false" uuid="7D07F449-79CC-442D-8A6F-F9D528A37060"><relationalOp displayName="During" type="DURING"><setOp displayName="UNION" type="union"><elementRef displayName="Macular Exam : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" type="qdm"><attribute attrUUID="42fe2870-a2a2-44f0-9cbb-38897386a051" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-57fe7eeb37f0"/></elementRef><elementRef displayName="Macular Exam : Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" type="qdm"><attribute attrUUID="052133d4-24e7-47ae-81f6-571fd7fa114e" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-57fe7eec37f1"/></elementRef></setOp><subTreeRef displayName="Occurrence A of EyeCareEncounters" id="A07FE269-0647-404E-8E32-F66D2CF4F58C" type="subTree"/></relationalOp></subTree><subTree displayName="DX Active Diabetic Retinopathy overlaps EyeCareEncounters" qdmVariable="false" uuid="3E8EC31E-1C39-4B08-A014-84AA4111DC21"><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Diabetic Retinopathy : Diagnosis, Active" id="227f6648-fc49-42e6-9f0e-6f8a96d330e1" type="qdm"/><subTreeRef displayName="Occurrence A of EyeCareEncounters" id="A07FE269-0647-404E-8E32-F66D2CF4F58C" type="subTree"/></relationalOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 2" type="initialPopulation" uuid="7155F098-3D41-44B5-AC3A-65BA00C3093C"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age greater than or equal to 18 at MP" id="989D2EBB-D8D9-4F2E-823D-BD0E59CD7D78" type="subTree"/><subTreeRef displayName="DX Active Diabetic Retinopathy overlaps EyeCareEncounters" id="3E8EC31E-1C39-4B08-A014-84AA4111DC21" type="subTree"/></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="B983156C-1092-4331-A35A-69E375BD5400"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Denominator Exceptions 1" type="denominatorExceptions" uuid="2DA5A07A-8435-4246-9680-1170BAEF9D6D"><logicalOp displayName="OR" type="or"><comment displayName="comment" type="comment"/><subTreeRef displayName="Union of Diag Study Perf not done during EyeCareEncounters" id="7D07F449-79CC-442D-8A6F-F9D528A37060" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="62DE0A25-2910-4C57-B3F9-4EB434C40A77"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Diagnostic Study Perf Macular Exam result Level of Sev during EyeCareEnc" id="3AE635EB-AF32-4659-ADA5-647388DA247D" type="subTree"/></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="0a3ac741-4ff5-444a-939b-c61d840b8549"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="d60cacea-ccaf-4f39-bd3e-b49315e0064a"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="19947bd1-ac87-4c2c-accd-3142510fde5c"/></group></measureGrouping><elementLookUp><qdm datatype="Patient Characteristic Birthdate" id="bbfad54d-48d8-416c-8d39-9ed13b87211e" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="bbfad54d-48d8-416c-8d39-9ed13b87211e" version="1.0"/><qdm datatype="Encounter, Performed" id="2bcb769b-ead5-4ff0-b60b-fb9f092fc4ef" name="Care Services in Long-Term Residential Facility" oid="2.16.840.1.113883.3.464.1003.101.12.1014" suppDataElement="false" taxonomy="Grouping" uuid="2bcb769b-ead5-4ff0-b60b-fb9f092fc4ef" version="1.0"/><qdm datatype="Diagnosis, Active" id="227f6648-fc49-42e6-9f0e-6f8a96d330e1" name="Diabetic Retinopathy" oid="2.16.840.1.113883.3.526.3.327" suppDataElement="false" taxonomy="Grouping" uuid="227f6648-fc49-42e6-9f0e-6f8a96d330e1" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d61-56a7-013e-57fe7eea37da" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d61-56a7-013e-57fe7eea37da" version="1"/><qdm datatype="Patient Characteristic Expired" id="a85d92bf-cfd1-426c-ad37-9ae1cb5cfdd9" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="a85d92bf-cfd1-426c-ad37-9ae1cb5cfdd9" version="1.0"/><qdm datatype="Encounter, Performed" id="8f34391b-9bf2-49fb-bebc-72a137772377" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="8f34391b-9bf2-49fb-bebc-72a137772377" version="1.0"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-57fe7eeb37ed" name="Level of Severity of Retinopathy Findings" oid="2.16.840.1.113883.3.526.3.1283" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-57fe7eeb37ed" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-57fe7eeb37ee" name="Macular Edema Findings Absent" oid="2.16.840.1.113883.3.526.3.1284" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-57fe7eeb37ee" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-57fe7eeb37ef" name="Macular Edema Findings Present" oid="2.16.840.1.113883.3.526.3.1320" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-57fe7eeb37ef" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnostic Study, Performed" id="40280381-3d61-56a7-013e-57fe7eec37f2" name="Macular Exam" oid="2.16.840.1.113883.3.526.3.1251" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-57fe7eec37f2" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013e-57fe7eeb37dd" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013e-57fe7eeb37dd" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-57fe7eeb37f0" name="Medical Reason" oid="2.16.840.1.113883.3.526.3.1007" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-57fe7eeb37f0" version="1"/><qdm datatype="Encounter, Performed" id="68ef4e4b-4749-4cc1-9d36-c6dbd7aaea58" name="Nursing Facility Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1012" suppDataElement="false" taxonomy="Grouping" uuid="68ef4e4b-4749-4cc1-9d36-c6dbd7aaea58" version="1.0"/><qdm datatype="Encounter, Performed" id="454f4c4b-4f9f-4ecc-8a7d-46f5cad09f41" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="454f4c4b-4f9f-4ecc-8a7d-46f5cad09f41" version="1.0"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-57fe7eea37d8" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3d61-56a7-013e-57fe7eea37d8" version="1"/><qdm datatype="Encounter, Performed" id="05ab18cc-304f-4661-a90a-3e8ab02c4081" name="Ophthalmological Services" oid="2.16.840.1.113883.3.526.3.1285" suppDataElement="false" taxonomy="Grouping" uuid="05ab18cc-304f-4661-a90a-3e8ab02c4081" version="1.0"/><qdm datatype="Encounter, Performed" id="fc8a184a-8b37-4029-a268-c878ef687efb" name="Outpatient Consultation" oid="2.16.840.1.113883.3.464.1003.101.12.1008" suppDataElement="false" taxonomy="Grouping" uuid="fc8a184a-8b37-4029-a268-c878ef687efb" version="1.0"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-57fe7eec37f1" name="Patient Reason" oid="2.16.840.1.113883.3.526.3.1008" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-57fe7eec37f1" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d61-56a7-013e-57fe7eeb37db" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3d61-56a7-013e-57fe7eeb37db" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d61-56a7-013e-57fe7eea37d9" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d61-56a7-013e-57fe7eea37d9" version="1"/></elementLookUp></measure>